• Aucun résultat trouvé

[PDF] Top 20 Cost-effectiveness model for sofosbuvir in chronic hepatitis C

Has 10000 "Cost-effectiveness model for sofosbuvir in chronic hepatitis C" found on our website. Below are the top 20 most common "Cost-effectiveness model for sofosbuvir in chronic hepatitis C".

Cost-effectiveness model for sofosbuvir in chronic hepatitis C

Cost-effectiveness model for sofosbuvir in chronic hepatitis C

... al. Cost-effectiveness of pegylated interferon and ribavirin for patients with chronic hepatitis C treated in routine clinical ...Boceprevir for untreated chronic ... Voir le document complet

1

Managing drug-drug interactions with new direct-acting antiviral agents in chronic hepatitis C.

Managing drug-drug interactions with new direct-acting antiviral agents in chronic hepatitis C.

... advance in hepatitis C virus (HCV) infection ...inhibitors sofosbuvir and dasabuvir. They are approved in an interferon-free regimen, with or without ribavirin [4, 5] and can cure 80–90% of ... Voir le document complet

25

Simulation-based estimates of effectiveness and cost-effectiveness of smoking cessation in patients with chronic obstructive pulmonary disease.

Simulation-based estimates of effectiveness and cost-effectiveness of smoking cessation in patients with chronic obstructive pulmonary disease.

... be cost-effective. In particular, a smoking cessation programme combining intensive counseling and phar- macotherapy with a ...result in an incremental cost-effectiveness ratio (ICER) ... Voir le document complet

10

Simulation-Based Estimates of the Effectiveness and Cost-Effectiveness of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease in France

Simulation-Based Estimates of the Effectiveness and Cost-Effectiveness of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease in France

... uncertainty in the model was evaluated by means of one-way sensitivity ...mate for a given model parameter was varied, while keeping the other parameters constant, within a range of likely ... Voir le document complet

12

Effectiveness and cost of hepatitis C virus cryoglobulinemia vasculitis treatment: from interferon-based to direct acting antivirals era

Effectiveness and cost of hepatitis C virus cryoglobulinemia vasculitis treatment: from interferon-based to direct acting antivirals era

... performed in a tertiary French ...2016 in the Department of Internal Medicine and Clinical Immunology of La Pitié-Salpêtrière Hospital, Paris, France, was ...and chronic active HCV infection ... Voir le document complet

30

Long‐term clinical benefits of Sofosbuvir‐based direct antiviral regimens for patients with chronic hepatitis C in Central and West Africa

Long‐term clinical benefits of Sofosbuvir‐based direct antiviral regimens for patients with chronic hepatitis C in Central and West Africa

... cohort model Legend: The ovals boxes represent the different health states of the model including fibrosis stage measured by the METAVIR scoring system (F0, F1, F2, F3), CC, DC, HCC and CHC ...At ... Voir le document complet

25

Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study.

Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study.

... benefit for the cost that is ...published cost-effectiveness models [22-26], our modeling study made several updates in the model structure and ...opportunity for a ... Voir le document complet

18

Cost Effectiveness of Intermittent Preventive Treatment of Malaria in Infants in Ghana

Cost Effectiveness of Intermittent Preventive Treatment of Malaria in Infants in Ghana

... The cost of transportation of health staff and materials from the health facilities to the outreach locations were calculated by adding the cost of fuel used to drive from the health center to outreach ... Voir le document complet

15

Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma

Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma

... even in the cases hard to cure before [47]. In patients previously treated with older, IFN-based regimens, SVR was significantly associated with reduced but not eliminated future risk of HCC development ... Voir le document complet

14

Evaluation of cost-effectiveness criteria in supply chain management : case study

Evaluation of cost-effectiveness criteria in supply chain management : case study

... multi-objective model was devel- oped by Sabri and Beamon [6] and applied in strategic planning and operational ...strategic model was to minimize the costs of the chain, while the objective of ... Voir le document complet

13

Chronic hepatitis C virus infection, a new cardiovascular risk factor?

Chronic hepatitis C virus infection, a new cardiovascular risk factor?

... In addition to common cardiovascular risk factors ...manifestations. Hepatitis C virus (HCV) infection has been associated to a very large number of extrahepatic manifestations in various tissues ... Voir le document complet

20

Performance and Cost Effectiveness of Caching in Mobile Access Networks

Performance and Cost Effectiveness of Caching in Mobile Access Networks

... necessary in any case to pro- vide content providers adequate control over delivery of their ...correct. For the PGW, reactive caching is still only just effec- tive for the larger ...preferable ... Voir le document complet

11

Primary prophylaxis of disseminated histoplasmosis in HIV patients in French Guiana: arguments for cost effectiveness.

Primary prophylaxis of disseminated histoplasmosis in HIV patients in French Guiana: arguments for cost effectiveness.

... Since in our historical database 43% percent of patients with DH receive liposomal amphotericine B, we proportionally added that cost to hospital ...The cost of prophylaxis was obtained by ... Voir le document complet

7

Assessing the cost‐effectiveness of integrated passives

Assessing the cost‐effectiveness of integrated passives

... final cost is calculated using the general formula in Eq. 1. For this step we used the Modular Optimization En- vironment MOE, a cost modeling tool developed at ETH ...production model ... Voir le document complet

5

Tight Bounds for Broadcasting in the Linear Cost Model

Tight Bounds for Broadcasting in the Linear Cost Model

... 101 - 54602 Villers lès Nancy Cedex France Unité de recherche INRIA Rennes : IRISA, Campus universitaire de Beaulieu - 35042 Rennes Cedex France Unité de recherche INRIA Rhône-Alpes : 65[r] ... Voir le document complet

25

Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women

Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women

... easy in Singapore with ...send for bone densitometry using the Osteoporosis Self-Assessment tool for Asians (OSTA) and/or FRAX® have recently been suggested for Singapore [ 47 ...Guidance ... Voir le document complet

12

Host-targeting agents for prevention and treatment of chronic hepatitis C - perspectives and challenges.

Host-targeting agents for prevention and treatment of chronic hepatitis C - perspectives and challenges.

... archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or ...institutions in France or abroad, or from public or private research ... Voir le document complet

4

Prescription and efficacy of daclatasvir and sofosbuvir +/- ribavirin for hepatitis C infection, including patient-reported outcomes, in routine practice in three European countries: the CMPASS-EU cohort study.

Prescription and efficacy of daclatasvir and sofosbuvir +/- ribavirin for hepatitis C infection, including patient-reported outcomes, in routine practice in three European countries: the CMPASS-EU cohort study.

... STATEMENT Hepatitis C is a chronic, debilitating liver infection estimated by the WHO to kill almost 400,000 people ...annually. Hepatitis C may be cured by a course of antiviral drugs, such as the ... Voir le document complet

16

Sofosbuvir in combination with simeprevir +/- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis: a real-life experience from Belgium

Sofosbuvir in combination with simeprevir +/- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis: a real-life experience from Belgium

... Sofosbuvir in combination with simeprevir +/- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis: real-life experience from Belgium Christophe Moreno 1 , Luc ... Voir le document complet

1

The cost effectiveness of the solicitation process for research and development proposals

The cost effectiveness of the solicitation process for research and development proposals

... A questionaire was sent to each with.in a week after the government had issued its request for proposal..; In the questionaire companies were asked about the factors which they considere[r] ... Voir le document complet

44

Show all 10000 documents...